|
|
Mahdi Fallah, MD, PhD
Address: Haukkamäenkatu, 1 E 55
33560, Tampere, FINLAND
2003-7: PhD in Epidemiology, University of Tampere, Tampere, Finland
1991-9: MD, Isfahan University of Medical Sciences, Isfahan, Iran
2006-present: Epidemiologist, Data Manager/Analyst, Tampere University Hospital, Finland
2007: Part-time assistant professor (teaching practical sessions of epidemiology course), School of Public Health, University of Tampere, Finland
2002-3: Member, Cancer Registry Unit, Digestive Diseases Research Center, Tehran, Iran
2001-2: Physician, Treatment Office, Kashan University of Medical Sciences, Kashan, Iran
2000-1: Physician, Diabetes Treatment Unit, Kashan, Iran
1999-2000: Physician, Internal Emergency Center, Kashan, Iran
1. Fallah M. Cancer Incidence in Five Provinces of Iran, Ardebil, Gilan, Mazandaran, Golestan and Kerman, 1996-2000 [PhD monograph: Available at http://acta.uta.fi/pdf/978-951-44-6876-6.pdf]. Acta Universitatis Tamperensis, Faculty of Medicine at University of Tampere, Tampere, Finland, 2007:1-193.
2. Fallah M, Kharazmi E. New methods to deal with cases with unknown age cases in cancer registry data. Asian Pac J Cancer Prev (In Press).
3. Fallah M, Kharazmi E. Correction for under-ascertainment in cancer cases in the very elderly (aged 75+): External reference method. Cancer Cause and Control (In Press, PMID: 18322815).
4. Fallah M, Kharazmi E. Substantial under-estimation in cancer incidence estimates for developing countries due to under-ascertainment in elderly cancer cases. Cancer letters 2008;264(2):250-255.
5. Fallah M, Kharazmi E. Iran cancer incidence should be corrected for under-ascertainment in cancer cases in the elderly. Asian Pac J Cancer Prev 2007;8(3):348-352.
6. Fallah M, Kharazmi E. A method to adjust for ascertainment bias in the evaluation of cancer registry data. Asian Pac J Cancer Prev 2007;8(1):113-8.
7. Fallah M, Kharazmi E. Global cancer incidence corrected for under-ascertainment in cancer cases in the elderly (aged 65+) [Abstract]. Int J Hemat Onc Bon Marr Transpl 2007;4(Suppl. 1):59.
8. Fallah M, Kharazmi E. Cancer incidence in developing countries corrected for under-ascertainment in cancer cases in the elderly (aged 65+) [Abstract]. Int J Hemat Onc Bon Marr Transpl 2007;4(Suppl. 1):59.
9. Kharazmi E, Fallah M, Luoto R. Cardiovascular diseases attributable to hysterectomy: a population-based study. Acta Obstet Gynecol Scand 2007;86(12):1476-83.
10. Kharazmi E, Kaaja R, Fallah M, Luoto R. Pregnancy-related factors and the risk of isolated systolic hypertension. Blood Press. 2007;16(1):50-5.
11. Kharazmi E, Moilanen L, Fallah M, Kaaja R, Kattainen A, Kahonen M, Jula A, Kesaniemi A, Luoto R. Reproductive history and carotid intima-media thickness. Acta Obstet Gynecol Scand 2007;86(8):995-1002.
12. Samadi F, Babaei M, Yazdanbod A, Fallah M et al. Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med 2007;10(1):32-7.
13. Peltola J, Peltola M, Auvinen A, Raitanen J, Fallah M, Keränen T. Retention rates of new anti-epileptic drugs in refractory localization-related epilepsy: A single-center study. Acta Neur Scand (In Press).
14. Peltola J, Peltola M, Auvinen A, Keränen T, Liimatainen S, Kharazmi E, Fallah M. Clinical determinants in patients with refractory epilepsy exposed to levetiracetam; a single center study. Acta Neur Scand 2008;117(5):332-6.
1. Fallah M, Kharazmi E. Global cancer incidence corrected for under-ascertainment in cancer cases in the elderly (2008).
2. Liimatainen S, Fallah M, Kharazmi E, Peltola M, Peltola J. Increased interleukin-6 levels in temporal lobe epilepsy (2008).
3. Liimatainen S, Peltola M, Fallah M, Kharazmi E, Haapala A-M, Peltola J. Prevalence of antiphospholipid antibodies in well-evaluated therapy resistant focal epilepsy is related to recurrent seizures (2008).
4. Liimatainen S, Fallah M, Kharazmi E, Peltola M, Peltola J. High levels of glutamic acid decarboxylase antibodies are found in a subgroup of patients with temporal lobe epilepsy (2008).
1. Fallah M. Girl or boy? A Scientific Method of Sex Preselection [Book]. Arghanoon Publication, Tehran, 1998, reprinted in 2000, 2002 and 2006, pp 1-384.
2. Fallah M. Young couples’ attitudes to the gender and desired number of children [MD thesis]. Department of Community Medicine, Isfahan University of Medical Sciences, Isfahan, 1999.
1. Fallah M, Kharazmi E. Global cancer incidence corrected for under-ascertainment in cancer cases in the elderly (aged 65+). The 19th Asia Pacific Cancer Conference. Tehran, Iran, 15 Nov 2007.
2. Fallah M, Kharazmi E. A correction method for under-ascertainment in cancer cases in the very elderly in the very elderly. The European Network of Cancer Registries (ENCR) General Meeting. Ljubljana, Slovenia, 21 Sep 2007.
3. Fallah M, Kharazmi E. Global cancer incidence corrected for under-ascertainment in cancer cases in the very elderly. The 29th Annual Meeting of the International Association of Cancer Registries. Ljubljana, Slovenia, 18 Sep 2007.
4. Fallah M. Iran and cancer registry. Public defense of doctoral dissertation. Faculty of Medicine, University of Tampere, Tampere, Finland, 20 Mar 2007 (Opponent: Dr Maxwell Parkin from Oxford University).
5. Fallah M. Cancer Occurrence in Caspian Littoral area of Iran. Seminar of Cancer Epidemiology in Iran. School of Public Health, Tehran, Iran, Mar 2003.
Fallah M, Kharazmi E. A method to adjust for ascertainment bias in the evaluation of cancer registry data. The 19th Asia Pacific Cancer Conference. Tehran, Iran, 15-17 Nov 2007.
Conferences and Seminars Attendance
1. The Nordic Research Seminar on “Vaccines for Global Health” Gothenburg, Sweden, 26-28 March 2008.
2. “In the 19th Asia Pacific Cancer Conference (APCC)”, Tehran, Iran, 15-17 Nov 2007.
3. “The European Network of Cancer Registries (ENCR) General Meeting”, Ljubljana, Slovenia, 21 Sep 2007.
4. “The 29th Annual Meeting of International Association of Cancer Registries (IACR2007)”, Ljubljana, Slovenia, 17- 20 Sep 2007.
5. The 1st Nordic Research Seminar on “Emerging Trends in Sexual and Reproductive Health” Gothenburg, Sweden, 10-12 Sep 2007.
6. “Perspectives of pharmacoepidemiology in Finland and in Europe”, 2 Nov 2006, Helsinki, Finland.
7. “The 3rd Regional Conference of Asian Pacific Organization for Cancer Prevention (APOCP) GI Cancer Control”, Zibakenar, Rasht, Iran, 25-27 Apr 2007.
Reviewer of Journals: Cancer Letter, and Environmental Health Insights. Participated workshops: Medical education technology, access to biomedical information resources, modern methods of medical education, evidence-based medicine, and ICD-O-3 coding.
1999-present: Member of Iran Medical Council
Excellent at English; Academic IELTS score 6.5 in 2002; Beginner at Finnish and French
Professional user of Microsoft Office package (Word, Excel, Access, PowerPoint, Outlook), STATA, SPSS, OVID/Medline, Refworks, Reference Manager, and Canreg-4 Software for Cancer Registration
1. Associate Prof. Jukka Peltola, MD, PhD;
Address: Department of Neurology, Tampere University Hospital, P.O. Box 2000, 33521-TRE, Finland
2. Prof. Anssi Auvinen, MD, PhD;
Address: School of Public Health, University of Tampere, FIN-33014, Tampere, Finland
3. Dr. D. Maxwell Parkin;
Address: Clinical Trials and Epidemiological Studies Unit, University of Oxford, Richard Doll Building, Roosevelt Drive, Headington, Oxford, OX3 7DG, UK